{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:42:38Z","timestamp":1778226158448,"version":"3.51.4"},"reference-count":25,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":422,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatrics International"],"published-print":{"date-parts":[[2000,10,29]]},"abstract":"<jats:p> <jats:bold>Abstract <jats:italic>Background<\/jats:italic><\/jats:bold>: There is a significant association between hepatoblastoma and low birthweight. A case\u2010control study was conducted to reveal risk factors for hepatoblastoma in children of extremely low birthweight (&lt;1000 g).<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Methods<\/jats:italic>\n          <\/jats:bold>: Prenatal and postnatal histories, including parental histories, of 12 hepatoblastoma cases and 75 birthweight\u2010matched controls were compared.<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Results<\/jats:italic>\n          <\/jats:bold>: The gestational age of the hepatoblastoma cases (23\u201332 weeks; median 25 weeks), tended to be lower than that of the controls (23\u201336 weeks; median, 27 weeks; <jats:italic>P<\/jats:italic>=0.072). The time for an infant\u2019s bodyweight to return to the same level as the birthweight also tended to be longer in hepatoblastoma cases than in controls (<jats:italic>P<\/jats:italic>=0.055). All hepatoblastoma cases received oxygen therapy for a period of 4\u2013508 days (median 114 days), which was significantly longer than the 0\u2013366 days (median 62 days) in the controls (<jats:italic>P<\/jats:italic>=0.022). Furosemide was given to all hepatoblastoma cases and was used for a significantly longer period in these infants (6\u2013460 days; median 89 days) than in the controls (0\u2013241 days; median 44 days <jats:italic>P<\/jats:italic>=0.027). A univariate Cox regression demonstrated that the time taken to regain bodyweight at birth and the duration of both oxygen therapy and furosemide treatment were significantly associated with the development of hepatoblastoma (hazard ratio (HR)=1.044, <jats:italic>P<\/jats:italic>=0.013; HR=1.006, <jats:italic>P<\/jats:italic>=0.001; and HR=1.007, <jats:italic>P<\/jats:italic>=0.001, respectively). Although there were significant correlations between the factors, a multivariate Cox regression analysis identified the duration of oxygen therapy as a significant independent risk factor (HR=1.006, <jats:italic>P<\/jats:italic>=0.001).<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Conclusions<\/jats:italic>\n          <\/jats:bold>: Oxygen therapy and furosemide treatment, along with the rate of growth, are risk factors for the development of hepatoblastoma in children of extremely low birthweight, and the duration of oxygen therapy is the most important factor in predicting the development of hepatoblastoma. Further studies are necessary to determine the real reasons for the development of hepatoblastoma and to protect children of low birthweight from the development of cancer.<\/jats:p>","DOI":"10.1046\/j.1442-200x.2000.01287.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T16:49:56Z","timestamp":1047487796000},"page":"492-498","source":"Crossref","is-referenced-by-count":44,"title":["Case\u2010control study of perinatal factors and hepatoblastoma in children with an extremely low birthweight"],"prefix":"10.1111","volume":"42","author":[{"given":"Kenichi","family":"Maruyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takenobu","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Tsuchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Tanimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"5041","article-title":"Loss of maternal alleles on chromosome arm 11p in hepatoblastoma.","volume":"54","author":"Albrecht S","year":"1994","journal-title":"Cancer Res."},{"key":"e_1_2_6_3_2","first-page":"5007","article-title":"Biallelic inactivation of the APC gene in hepatoblastoma.","volume":"55","author":"Kurahashi H","year":"1995","journal-title":"Cancer Res."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.6.867"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","unstructured":"BuckleyJD SatherH RuccioneKet al.A case\u2010control study of risk factors for hepatoblastoma: A report from the Childrens Cancer Study Group.Cancer1989;64: 1169\u201376.","DOI":"10.1002\/1097-0142(19890901)64:5<1169::AID-CNCR2820640534>3.0.CO;2-I"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70239-7"},{"key":"e_1_2_6_7_2","first-page":"3032","article-title":"Increased risk of hepatoblastoma among immature children with a lower birth weight.","volume":"58","author":"Tanimura M","year":"1998","journal-title":"Cancer Res."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70380-4"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70084-8"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19980501)82:9<1789::aid-cncr27>3.3.co;2-b"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-200x.1999.01022.x"},{"key":"e_1_2_6_12_2","unstructured":"WinterbournCC.Free radicals oxidants and antioxidants. In: Gluckman PD Heymann MA (eds).Pediatrics and Perinatology 2nd edn. Arnold London. 1996; 168\u201375."},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.bmb.a072639"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/fn.70.2.F107"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/fn.71.1.F40"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000244472"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(95)00531-5"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/18.4.859"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.26.12808"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/16.4.831"},{"key":"e_1_2_6_21_2","first-page":"569","article-title":"Dexamethasone stimulation of fetal lung antioxidant enzyme activity in parallel with surfactant stimulation.","volume":"75","author":"Frank L","year":"1985","journal-title":"Pediatrics"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199112000-00004"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70202-6"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/jat.2550100510"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(74)80115-0"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(82)80242-4"}],"container-title":["Pediatrics International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1442-200x.2000.01287.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1442-200x.2000.01287.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T18:05:25Z","timestamp":1697306725000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1442-200x.2000.01287.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10,29]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,10,29]]}},"alternative-id":["10.1046\/j.1442-200x.2000.01287.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1442-200x.2000.01287.x","archive":["Portico"],"relation":{},"ISSN":["1328-8067","1442-200X"],"issn-type":[{"value":"1328-8067","type":"print"},{"value":"1442-200X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10,29]]}}}